DMPHF.US Dermapharm Holding SE

Healthcare Pharmaceuticals USA Stocks
47.69 USD
Close of Nov 13, 2026
38.80 53.00
Market cap
USD 2.36B
P/E
14.8x
P/B
3.93x
ROE
21.8%
Dividend yield
2.11%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is DMPHF.US undervalued?

Graham number
Price47.69
Graham value29.69
Premium60.6%

DMPHF.US trades 60.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Dermapharm Holding SE fundamental analysis

No fundamental analysis for Dermapharm Holding SE yet.

Dermapharm Holding SE stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal e…

Full company profile